This K43 Emerging Global Leader Award is a key funding opportunity aimed at developing independent clinical investigators for leadership roles in global health. Specifically, it targets emerging leaders who will conceive, design, and execute independent clinical trials. This grant is a reissue of the established K43 program, updated to ensure full alignment with current clinical trials policies and regulations. It supports talented researchers in advancing their careers and contributing significantly to global health challenges through high-quality, policy-compliant independent clinical research, fostering new generations of global health leaders committed to rigorous and ethical research practices.
Opportunity ID: 356724
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-295 |
| Funding Opportunity Title: | Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 15, 2024 |
| Last Updated Date: | Oct 15, 2024 |
| Original Closing Date for Applications: | Dec 03, 2026 |
| Current Closing Date for Applications: | Dec 03, 2026 |
| Archive Date: | Jan 08, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC’s Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC’s Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356724 Full Announcement-PAR-24-295 -> PAR-24-295-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00288128 | Nov 03, 2024 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289187 | Nov 27, 2024 | Dec 03, 2026 | View |
Package 1
Mandatory forms
356724 RR_SF424_5_0-5.0.pdf
356724 PHS398_CoverPageSupplement_5_0-5.0.pdf
356724 RR_OtherProjectInfo_1_4-1.4.pdf
356724 PerformanceSite_4_0-4.0.pdf
356724 RR_KeyPersonExpanded_4_0-4.0.pdf
356724 RR_Budget_3_0-3.0.pdf
356724 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf
356724 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356724 RR_SubawardBudget30_3_0-3.0.pdf
356724 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
356724 RR_SF424_5_0-5.0.pdf
356724 PHS398_CoverPageSupplement_5_0-5.0.pdf
356724 RR_OtherProjectInfo_1_4-1.4.pdf
356724 PerformanceSite_4_0-4.0.pdf
356724 RR_KeyPersonExpanded_4_0-4.0.pdf
356724 RR_Budget_3_0-3.0.pdf
356724 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf
356724 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356724 RR_SubawardBudget30_3_0-3.0.pdf
356724 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
